Clinical Trial Update: The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind trial evaluating NAD replenishment therapy for atypical parkinsonism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticobasal Syndrome
• Multiple System Atrophy
• Progressive Supranuclear Palsy

Drugs mentioned

• NAD Replenishment Therapy

Snippet

Sponsor: Haukeland University Hospital | Conditions: Progressive Supranuclear Palsy, Multiple System Atrophy | Phase 2 | Status: RECRUITING